Journal of Critical Care
Volume 23, Issue 1 , Pages 5-10, March 2008

The impact of ventilator-associated pneumonia on the Canadian health care system☆

  • John G. Muscedere, MD

      Affiliations

    • Queens University, Kingston, Canada K7L 2V7
    • ,
  • Claudio M. Martin, MD

      Affiliations

    • University of Western Ontario, Ontario, Canada N6A 4G5
    • ,
  • Daren K. Heyland, MD, MSc

      Affiliations

    • Queens University, Kingston, Canada K7L 2V7
    • Corresponding Author InformationCorresponding author. Tel.: +1 613 549 6666#3339; fax: +1 613 548 1351.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Conflicts of interest: J Muscedere and D Heyland have received unrestricted research grants for studies in VAP unrelated to the present manuscript from Astra-Zeneca and Bayer Pharmaceuticals.

PII: S0883-9441(08)00004-X

doi:10.1016/j.jcrc.2007.11.012

Journal of Critical Care
Volume 23, Issue 1 , Pages 5-10, March 2008

Article Tools